Tim M. Mayleben
2015 - Esperion Therapeutics
In 2015, Tim M. Mayleben earned a total compensation of $5.8M as President and Chief Executive Officer at Esperion Therapeutics, a 667% increase compared to previous year.
Compensation breakdown
| Bonus | $228,000 |
|---|---|
| Option Awards | $5,008,892 |
| Salary | $480,000 |
| Other | $34,405 |
| Total | $5,751,297 |
Mayleben received $5M in option awards, accounting for 87% of the total pay in 2015.
Mayleben also received $228K in bonus, $480K in salary and $34.4K in other compensation.
Rankings
In 2015, Tim M. Mayleben's compensation ranked 1,318th out of 13,638 executives tracked by ExecPay. In other words, Mayleben earned more than 90.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,318 out of 13,638 | 90th |
Division Manufacturing | 459 out of 5,187 | 91st |
Major group Chemicals And Allied Products | 167 out of 1,857 | 91st |
Industry group Drugs | 128 out of 1,531 | 92nd |
Industry Pharmaceutical Preparations | 105 out of 1,179 | 91st |
Source: SEC filing on March 6, 2017.
Mayleben's colleagues
We found four more compensation records of executives who worked with Tim M. Mayleben at Esperion Therapeutics in 2015.
News
Landos Biopharma CEO Gregory Oakes receives $1.8M in 2022
April 19, 2023
Landos Biopharma Executive Vice President of Operations Jyoti RAC's 2021 pay jumps 195% to $2.8M
April 28, 2022
Esperion Therapeutics CEO Tim Mayleben's 2021 pay rises 19% to $8.2M
April 14, 2022
Esperion Therapeutics CEO Tim Mayleben's 2019 pay falls 89% to $1.1M
April 16, 2020
Esperion Therapeutics CEO Tim Mayleben's 2018 pay jumps 94% to $9.7M
April 18, 2019